Developing a complex intervention for the outpatient management of incidentally diagnosed pulmonary embolism in cancer patients

BMC Health Services Research

Volumn 13, Issue 1, 2013, Pages

  Palmer, June ^a   Bozas, George ^a   Stephens, Andrew ^a   Johnson, Miriam ^b   Avery, Ged ^a   O'Toole, Lorcan ^a   Maraveyas, Anthony ^a,b  

^a CASTLE HILL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF HULL   (United Kingdom)

Author keywords

Complex intervention; Incidental pulmonary embolism; Nurse lead; Outpatient management

Indexed keywords

AMBULATORY CARE; CLINICAL PATHWAY; COMPLICATION; HUMAN; INCIDENTAL FINDING; NEOPLASM; ORGANIZATION AND MANAGEMENT; PROCEDURES; PULMONARY EMBOLISM; REGISTER; RISK ASSESSMENT;

AMBULATORY CARE; CRITICAL PATHWAYS; HUMANS; INCIDENTAL FINDINGS; NEOPLASMS; PULMONARY EMBOLISM; REGISTRIES; RISK ASSESSMENT;

EID: 84879434051     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-13-235     Document Type: Article

References (27)

1. Cardiology patient pages. Pulmonary embolism and deep vein thrombosis. Goldhaber SZ, Morrison RB, Circulation 2002 106 12 1436 1438 10.1161/01.CIR.0000031167.64088.F6 12234943
2. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Chew HK, Wun T, Harvey D, Zhou H, White RH, Arch Intern Med 2006 166 4 458 464 16505267
3. Cancer, clots and consensus: new understanding of an old problem. Lyman GH, Khorana AA, J Clin Oncol 2009 27 29 4821 4826 10.1200/JCO.2009.22.3032 19752337
4. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, Greer IA, Heit JA, Hutchinson JL, Kakkar AK, et al. Thromb Haemost 2007 98 4 756 764 17938798 (Pubitemid 47555066)
5. Does clinical method mask significant VTE-related mortality and morbidity in malignant disease? Maraveyas A, Johnson M, Br J Cancer 2009 100 12 1837 1841 10.1038/sj.bjc.6605091 19491905
6. Clinically unsuspected pulmonary embolism-an important secondary finding in oncology CT. Sebastian AJ, Paddon AJ, Clin Radiol 2006 61 1 81 85 10.1016/j.crad.2005.09.002 16356820 (Pubitemid 43045607)
7. Incidental venous thromboembolism in oncology patients. Khorana AA, O'Connell C, Agnelli G, Liebman HA, Lee AY, Subcommittee on H, Malignancy of the SSCotI, J Thromb Haemost 2012 10 12 2602 2604 10.1111/jth.12023 23362525
8. Prevalence and significance of asymptomatic venous thromboembolic disease found on oncologic staging CT. Cronin CG, Lohan DG, Keane M, Roche C, Murphy JM, AJR Am J Roentgenol 2007 189 1 162 170 10.2214/AJR.07.2067 17579167 (Pubitemid 46983207)
9. Unsuspected pulmonary emboli in cancer patients: clinical correlates and relevance. O'Connell CL, Boswell WD, Duddalwar V, Caton A, Mark LS, Vigen C, Liebman HA, J Clin Oncol 2006 24 30 4928 4932 10.1200/JCO.2006.06.5870 17050877 (Pubitemid 46630922)
10. Prevalence and clinical history of incidental, asymptomatic pulmonary embolism: a meta-analysis. Dentali F, Ageno W, Becattini C, Galli L, Gianni M, Riva N, Imberti D, Squizzato A, Venco A, Agnelli G, Thromb Res 2010 125 6 518 522 10.1016/j.thromres.2010.03.016 20451960
11. Safety of outpatient treatment in acute pulmonary embolism. Erkens PM, Gandara E, Wells P, Shen AY, Bose G, Le Gal G, Rodger M, Prins MH, Carrier M, J Thromb Haemost 2010 8 11 2412 2417 10.1111/j.1538-7836.2010.04041.x 20735722
12. Developing and evaluating complex interventions: new guidance. Medical-Research-Council, 2008 http://www.mrc.ac.uk/Utilities/Documentrecord/ index.htm?d=MRC004871 (Accessed 30/06/2013)
13. Outpatient treatment and early discharge of symptomatic pulmonary embolism: a systematic review. Squizzato A, Galli M, Dentali F, Ageno W, Eur Respir J 2009 33 5 1148 1155 10.1183/09031936.00133608 19407049
14. Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients. Siragusa S, Arcara C, Malato A, Anastasio R, Valerio MR, Fulfaro F, Lo Coco L, Grimaudo S, Bajardi G, Abbadessa V, et al. Ann Oncol 2005 16 Suppl 4 v136 iv139 15923414
15. Home-treatment of deep vein thrombosis in patients with cancer. Ageno W, Grimwood R, Limbiati S, Dentali F, Steidl L, Wells PS, Haematologica 2005 90 2 220 224 15710575 (Pubitemid 40293284)
16. Validation of a clinical prognostic model to identify low-risk patients with pulmonary embolism. Aujesky D, Perrier A, Roy PM, Stone RA, Cornuz J, Meyer G, Obrosky DS, Fine MJ, J Intern Med 2007 261 6 597 604 10.1111/j.1365-2796. 2007.01785.x 17547715 (Pubitemid 46835983)
17. The inter-rater reliability of the Pulmonary Embolism Severity Index. Fraga M, Taffe P, Mean M, Hugli O, Witzig S, Waeber G, Aujesky D, Thrombosis and haemostasis 2010 104 6 1258 1262 10.1160/TH10-07-0426 20838750
18. Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy. Jimenez D, Yusen RD, Curr Opin Pulm Med 2008 14 5 414 421 10.1097/MCP.0b013e3283043e44 18664971
19. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Aujesky D, Roy PM, Verschuren F, Righini M, Osterwalder J, Egloff M, Renaud B, Verhamme P, Stone RA, Legall C, et al. Lancet 2011 378 9785 41 48 10.1016/S0140-6736(11)60824-6 21703676
20. Derivation and validation of a multivariate model to predict mortality from pulmonary embolism with cancer: The POMPE-C tool. Kline JA, Roy PM, Than MP, Hernandez J, Courtney DM, Jones AE, Penaloza A, Pollack CV Jr, Thromb Res 2012 129 5 194 e199 10.1016/j.thromres.2012.03.015 22475313
21. A clinical prognostic model for the identification of low-risk patients with acute symptomatic pulmonary embolism and active cancer. den Exter PL, Gomez V, Jimenez D, Trujillo-Santos J, Muriel A, Huisman MV, Monreal M, Registro Informatizado de la Enfermedad TromboEmbolica I, Chest 2013 143 1 138 145 10.1378/chest.12-0964 22814859
22. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. Lyman GH, Khorana AA, Falanga A, Clarke-Pearson D, Flowers C, Jahanzeb M, Kakkar A, Kuderer NM, Levine MN, Liebman H, et al. J Clin Oncol 2007 25 34 5490 5505 10.1200/JCO.2007.14.1283 17968019 (Pubitemid 350232226)
23. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. Lee AY, Levine MN, Baker RI, Bowden C, Kakkar AK, Prins M, Rickles FR, Julian JA, Haley S, Kovacs MJ, et al. N Engl J Med 2003 349 2 146 153 10.1056/NEJMoa025313 12853587 (Pubitemid 36818784)
24. Pulmonary embolism as an incidental finding in ambulatory cancer patients. Characteristics and outcome. Bozas G, Ramasamy S, Avery G, Maraveyas A, Thrombosis Research 2010 125 Supplement 2 i ix S1-S196
25. Systematic Training and Education for Practice (STEPs). Hull-and-East-Yorkshire-Hospital-Trust, 2008/2010
26. Department-of-Health, The NHS improvement plan putting people at the heart of public services. (Cm 6268) London: STO Publishing 2004
27. Outcome and characteristics of cancer patients with unsuspected PE managed under a specialised care pathway protocol-updated results. Maraveyas A, Palmer J, Avery G, Stephens A, Elliot M, Hunter J, Dean S, Bozas G, Thrombosis Research 2012 129 Supplement 1(0) 183